Cardinal Capital Management

Position in PFE — Pfizer Inc

CIK 1434845 RALEIGH, NC

Position in PFE

as of Jun 30, 2026 · filed Jul 21, 2026 Compact

Position Value

$2,998,850

-$474,196 QoQ

Shares Held

124,537

+0.7% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.37%

of 13F equity value

Holder Rank

#795

of 2,821 holders

Holding Since

Jun 2022

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Cardinal Capital Management holds $99,250,544 across 9 Drug Manufacturers - General names. PFE ranks #8 (3.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	26,505	$31,790,894
2	JNJ	Johnson & Johnson	114,813	$29,159,057
3	MRK	Merck & Co., Inc.	96,235	$12,366,197
4	NVS	Novartis AG	49,670	$7,784,282
5	BMY	Bristol Myers Squibb Co	105,075	$6,054,421
6	SNY	Sanofi	80,450	$3,431,997
7	GSK	GSK plc	62,101	$3,255,334
8	PFE	Pfizer Inc This page	124,537	$2,998,850

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,998,850	124,537	+0.7%	Shares	Sole	2026-07-21
2026-03-31	$3,473,046	123,684	+2.9%	Shares	Sole	2026-04-08
2025-12-31	$2,993,702	120,229	+26.5%	Shares	Sole	2026-01-30
2025-03-31	$2,408,921	95,064	+5.7%	Shares	Sole	2025-04-18
2024-12-31	$2,385,444	89,915	-2.8%	Shares	Sole	2025-01-31
2024-09-30	$2,677,123	92,506	+2.3%	Shares	Sole	2024-10-16
2024-06-30	$2,529,839	90,416	+1.8%	Shares	Sole	2024-07-12
2024-03-31	$2,464,505	88,811	+13.9%	Shares	Sole	2024-07-12
2023-12-31	$2,244,122	77,948	+157.0%	Shares	Sole	2024-07-12
2023-09-30	$1,006,012	30,329	+4.1%	Shares	Sole	2024-07-12
2023-06-30	$1,069,001	29,144	-66.9%	Shares	Sole	2024-07-12
2023-03-31	$3,588,156	87,945	+1.9%	Shares	Sole	2023-04-19
2022-12-31	$4,420,269	86,266	+3.7%	Shares	Sole	2023-01-23
2022-09-30	$3,640,875	83,201	+7.2%	Shares	Sole	2022-10-24
2022-06-30	$4,069,616	77,620	—	Shares	Sole	2022-08-04
No filing history on record for this holder in this stock.